Ranibizumab for Edema of the Macula in Diabetes: Protocol 3 With High Dose - the READ 3 Study
Public ClinicalTrials.gov record NCT01077401. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to investigate the safety, tolerability, bioactivity, and dose response of two different dosages (0.5 mg and 2.0 mg) of ranibizumab (RBZ) in patients with diabetic macular edema (DME).
Study identification
- NCT ID
- NCT01077401
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 152 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2010 (Type not available)
- Primary completion
- Mar 2012 (Actual)
- Completion
- Mar 2013 (Actual)
- Last update posted
- Apr 28, 2017
2010 – 2013
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Vitreous Associates | Beverly Hills | California | 90211 | — |
| University of California San Diego | La Jolla | California | 92037 | — |
| Doheny Eye Institute | Los Angeles | California | 90033 | — |
| East Bay Retina Institute | Oakland | California | 94609 | — |
| Retina Macula Institute | Torrance | California | 90503 | — |
| Retina Group of Florida | Fort Lauderdale | Florida | 33334 | — |
| Retina Institute of Hawaii | Honolulu | Hawaii | 96815 | — |
| Illinois Retina Associates | Joliet | Illinois | 60435 | — |
| University of Kansas | Prairie Village | Kansas | 66208 | — |
| Johns Hopkins University Wilmer Eye Institute | Baltimore | Maryland | 21287 | — |
| Eye Care Specialists | Kingston | Pennsylvania | 18704 | — |
| Black Hills Eye Institute | Rapid City | South Dakota | 57701 | — |
| Texas Retina Associates | Arlington | Texas | 76012 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01077401, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2017 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01077401 live on ClinicalTrials.gov.